Health and Safety Code § 489.001: DEFINITIONS
No bill in the 90th Legislature changes this section yet
Follow this section in Texas Bill Atlas: a bill filed later that changes it shows up as new.
Part of Health and Safety Code Chapter 489, with every bill that changes it.
Bills are matched to sections automatically from their text and can be missed, for example when a bill changes a whole chapter at once or renumbers sections. No bill listed here does not mean no bill changes this section.
Current law
Sec. 489.001. DEFINITIONS. In this chapter:
(1) "Investigational drug, biological product, or device" means a drug, biological product, or device that has successfully completed phase one of a clinical trial but has not yet been approved for general use by the United States Food and Drug Administration and remains under investigation in the clinical trial.
(2) "Terminal illness" means an advanced stage of a disease with an unfavorable prognosis that, without life-sustaining procedures, will soon result in death or a state of permanent unconsciousness from which recovery is unlikely.
Added by Acts 2015, 84th Leg., R.S., Ch. 502 (H.B. 21), Sec. 2, eff. June 16, 2015.
SUBCHAPTER B. ACCESS TO INVESTIGATIONAL DRUGS, BIOLOGICAL PRODUCTS, AND DEVICES FOR PATIENTS WITH TERMINAL ILLNESSES
Links
- This chapter as it stands now, Markdown copy of the Texas Legislative Council's statute files
- Official text on statutes.capitol.texas.gov
- RSS feed of actions on these bills
Texas Bill Atlas is an independent research tool, not an official state website.